NIH-funded research R01 grant

Intermittent fasting diet to help prostate cancer and metabolic health

Official title: Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes

Funded at Cedars-Sinai Medical Center · NIH-11357610 · Data updated 2026-11-12

A patient-facing plan tests a fasting-mimicking diet to help men with prostate cancer improve cancer control and metabolism.

More Prostate Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$681,082
NIH project number5R01CA280081-04
Project IDNIH-11357610 on NIH RePORTER

Who could benefit from this research

Could help

Adult men with prostate cancer undergoing standard therapy, especially those at risk for metabolic complications.

Less likely to help

Some individuals may not respond to the diet or may experience adverse effects from fasting.

What this research studies

This project looks at how a very low-calorie, plant-based fasting-mimicking diet given for 5 days each month affects prostate cancer outcomes and metabolic health in men on treatment. It builds on prior human and animal studies suggesting insulin, glucose, and IGF-1 changes can influence cancer growth and treatment side effects. The researchers will monitor markers in blood, weight, and overall health while men follow the diet in the context of their cancer care. The goal is to see if this approach can delay cancer progression and reduce metabolic risks associated with common therapies.

Why it matters

Potential benefit: If successful, this approach could help managing prostate cancer more effectively while also improving metabolic health and reducing treatment-related risks.

How similar studies have gone: Preliminary human data and multiple animal studies support potential benefits of fasting-mimicking approaches in cancer and metabolism.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Freedland, Stephen Jay — Cedars-Sinai Medical Center
  • Study coordinator: Freedland, Stephen Jay

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.